Literature DB >> 21764140

Infection of peripheral blood mononuclear cells with neuropathogenic equine herpesvirus type-1 strain Ab4 reveals intact interferon-α induction and induces suppression of anti-inflammatory interleukin-10 responses in comparison to other viral strains.

Bettina Wagner1, Christine Wimer, Heather Freer, Nikolaus Osterrieder, Hollis N Erb.   

Abstract

The recent increase in incidence, morbidity, and mortality of neurological disease induced by equine herpesvirus type 1 (EHV-1) has suggested a change of virulence of the virus. The exact mechanisms by which EHV-1 induces neurologic disease are not known. Environmental, viral, and host risk factors might contribute to neurological manifestation. Here, we investigated innate interferon-α (IFN-α), interleukin-10 (IL-10) and IL-4 responses after infection of equine peripheral blood mononuclear cells (PBMC) with EHV-1 using an available cytokine multiplex assay. Three viral strains representing an older isolate (RacL11), a recent abortigenic (NY03) and a neuropathogenic isolate (Ab4) were compared to identify differences in cytokine induction that might explain the increased pathogenicity of Ab4. Cytokine concentrations were also compared between foals, mares after birth, pregnant and non-pregnant mares to investigate whether immune responses to EHV-1 infection are influenced by age or pregnancy status. PBMC from all groups secreted high concentrations of anti-viral IFN-α in response to EHV-1. A reduced response was observed in foals compared to non-pregnant mares. EHV-1 infection induced moderate IL-10 and overall low IL-4 secretion. Ab4 infection resulted in a significant reduction of IL-10 responses in adult horses. IL-10 and IL-4 responses were lower in foals than in most mare groups. These data suggested that EHV-1 induces robust IFN-α secretion without major differences between viral strains. However, anti-inflammatory IL-10 production was significantly reduced after infection with neuropathogenic Ab4. The ability of this EHV-1 isolate to down-regulate IL-10 production might contribute to increased local inflammation and a higher risk for neurological manifestation of the disease after infection with Ab4.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21764140     DOI: 10.1016/j.vetimm.2011.06.032

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  14 in total

1.  Immunological correlates of vaccination and infection for equine herpesvirus 1.

Authors:  Laura B Goodman; Christine Wimer; Edward J Dubovi; Carvel Gold; Bettina Wagner
Journal:  Clin Vaccine Immunol       Date:  2011-12-28

2.  Equid Herpesvirus 1 Targets the Sensitization and Induction Steps To Inhibit the Type I Interferon Response in Equine Endothelial Cells.

Authors:  Fatai S Oladunni; Sanjay Sarkar; Stephanie Reedy; Udeni B R Balasuriya; David W Horohov; Thomas M Chambers
Journal:  J Virol       Date:  2019-11-13       Impact factor: 5.103

3.  Intranasal treatment with CpG-B oligodeoxynucleotides protects CBA mice from lethal equine herpesvirus 1 challenge by an innate immune response.

Authors:  Seong K Kim; Akhalesh K Shakya; Dennis J O'Callaghan
Journal:  Antiviral Res       Date:  2019-06-25       Impact factor: 5.970

4.  Genomic analysis and mRNA expression of equine type I interferon genes.

Authors:  Olivier Detournay; David A Morrison; Bettina Wagner; Behdad Zarnegar; Eva Wattrang
Journal:  J Interferon Cytokine Res       Date:  2013-06-17       Impact factor: 2.607

5.  Neonatal Immunization with a Single IL-4/Antigen Dose Induces Increased Antibody Responses after Challenge Infection with Equine Herpesvirus Type 1 (EHV-1) at Weanling Age.

Authors:  Bettina Wagner; Gillian Perkins; Susanna Babasyan; Heather Freer; Alison Keggan; Laura B Goodman; Amy Glaser; Sigurbjorg Torsteinsdóttir; Vilhjálmur Svansson; Sigríður Björnsdóttir
Journal:  PLoS One       Date:  2017-01-03       Impact factor: 3.240

6.  Equine PBMC Cytokines Profile after In Vitro α- and γ-EHV Infection: Efficacy of a Parapoxvirus Ovis Based-Immunomodulator Treatment.

Authors:  Erika S Hue; Eric A Richard; Christine I Fortier; Guillaume D Fortier; Romain Paillot; Rudiger Raue; Stéphane L Pronost
Journal:  Vaccines (Basel)       Date:  2017-09-19

7.  Genetic characterization of equid herpesvirus type 1 from cases of abortion in Poland.

Authors:  Karol Stasiak; Magdalena Dunowska; Simon F Hills; Jerzy Rola
Journal:  Arch Virol       Date:  2017-04-27       Impact factor: 2.574

8.  A Live-Attenuated Equine Influenza Vaccine Stimulates Innate Immunity in Equine Respiratory Epithelial Cell Cultures That Could Provide Protection From Equine Herpesvirus 1.

Authors:  Lila M Zarski; Wendy E Vaala; D Craig Barnett; Fairfield T Bain; Gisela Soboll Hussey
Journal:  Front Vet Sci       Date:  2021-06-10

9.  Replication characteristics of equine herpesvirus 1 and equine herpesvirus 3: comparative analysis using ex vivo tissue cultures.

Authors:  Haileleul Negussie; Yewei Li; Tesfaye Sisay Tessema; Hans J Nauwynck
Journal:  Vet Res       Date:  2016-01-15       Impact factor: 3.683

10.  Abortigenic but Not Neurotropic Equine Herpes Virus 1 Modulates the Interferon Antiviral Defense.

Authors:  Katrien C K Poelaert; Jolien Van Cleemput; Kathlyn Laval; Herman W Favoreel; Gisela Soboll Hussey; Roger K Maes; Hans J Nauwynck
Journal:  Front Cell Infect Microbiol       Date:  2018-09-12       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.